UNS.AX : Summary for UNILIFE CO CDI 60:1 - Yahoo Finance

U.S. Markets closed

Unilife Corporation (UNS.AX)


ASX - ASX Delayed Price. Currency in AUD
Add to watchlist
0.000.00 (0.00%)
At close: 4:10PM AEST
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close0.00
Open0.00
Bid0.00 x
Ask0.00 x
Day's Range0.00 - 0.01
52 Week Range0.00 - 0.14
Volume1,785,053
Avg. Volume1,663,862
Market Cap4.63M
BetaN/A
PE Ratio (TTM)-0.00
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • The Wall Street Journal11 days ago

    [$$] Unilife Files for Chapter 11, Seeking a Buyer

    Mounting losses caught up to medical device maker Unilife Corp. Wednesday as the company turned to bankruptcy in a bid to find a buyer for its business.

  • PR Newswire11 days ago

    Unilife Files for Chapter 11 Protection

    ASX: UNS) today announced that it has commenced a formal proceeding to restructure its balance sheet or to sell its assets as a going concern in order to better position the business for the future.  To facilitate this restructuring or sale, the Company filed voluntary petitions under chapter 11 of the U.S. Bankruptcy Code in the United States Bankruptcy Court for the District of Delaware (the "Court").  Unilife's foreign affiliates in Australia are not included in the filing but are expected to be included in the restructuring or sale.  Unilife's operations will remain ongoing during the chapter 11 process. The Company has obtained a commitment for a $7 million debtor-in-possession ("DIP") financing facility underwritten by an affiliate of OrbiMed Advisors.  Subject to Court approval, this DIP financing, combined with the Company's cash from operations, is expected to provide sufficient liquidity during the chapter 11 cases to support the company's continuing business operations and minimize disruption.

  • Associated Press2 months ago

    Unilife reports 2Q loss

    The York, Pennsylvania-based company said it had a loss of 92 cents per share. The medical device maker posted revenue of $2.3 million in the period. The company's shares closed at $2.28. A year ago, they ...